use of peripherally acting µ-opioid receptor antagonists (PAMORAs) may be the most effective approach to manage opioid-induced constipation (OIC), according to a recent review.
In an inpatient setting, it can be challenging to diagnose OIC since its symptom profile overlaps with other primary/secondary constipation types (J Clin Med 2023;12[19]:6148. doi: 10.3390/jcm12196148. Researchers noted there are many potential consequences associated with constipations, including increased use of
DECEMBER 8, 2023